Oxcarbazepinetabstruct (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 1)
Oxcarbazepine Tablet, Film Coated
Product Images NDC 0615-8567
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 0615-8567). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Oxcarbazepinetabfig1 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 2)
The given text provides results of the log-rank test along with its p-value to compare the survival distributions of two groups. It also presents a graph showing the time on trial (in days) from day 2 to day 11 for a group that received Oxcarbarspine treatment.*
Oxcarbazepinetabfig2 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 3)
Oxcarbazepinetabfig3 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 4)
The text describes the result of a log-rank test on a dataset. The p-value obtained from the test is 0.0001, indicating a statistically significant difference. The rest of the text appears to be distorted by and does not provide any useful information.*
Oxcarbazepinetabfig4 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 5)
This text is a statistical output of a survival analysis where a log-rank test was performed. The p-value obtained was 0.0001. There are some unreadable characters and incomplete words, but the figure shows the time to exit (in days) on the x-axis and the treatment groups (HIGH and LOW) on the y-axis. Therefore, the text seems to be a part of a scientific or medical research report on the comparison of the effectiveness of two treatments in terms of survival analysis.*
Oxcarbazipinetabcamberlogo1 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 6)
Oxcarbazipinetabcamberlogo2 (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 7)
Principal Display Panel 150 mg (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 8)
This is a medication description for Oxcarbazepine Tab USP 150 mg, prescribed under TasUP10mg, manufacturered by Annora for Camber. The pharmacy dispenses 30 tablets in a package and it is available for institutional use only. The container should be kept tight and the recommended controlled room temperature is 20°-25°C (68°- 77 F). See the insert or label for dosage information. There are several LOT numbers and expiration dates, but the packaging is trademarked by Omnicare, Inc.*
Principal Display Panel 300 mg (Oxcarbazepine Tabs 150 mg 300 mg 8447 8448 9)
This is a description of a medication called "Oxcarbazepine", which is available in 300mg tablets. The medication is manufactured by "Annora" for "Camber". It is a prescription drug and is available in a package labeled by "Vangard" in Glasgow, KY 42121. The lot number of the medication is "LOT 8448" with an expiration date of "EXP" mentioned several times. The package insert or label contains information about the dosage of the medication. The storage conditions specified are 20°C-25°C (68°-77 F) along with dispensing in a tight container. The medication is intended for "Institutional Use ONLY".*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
